Glenmark Pharmaceuticals has received the final approval from the United States Food & Drug Administration (USFDA) for its Topiramate Capsules USP, 15 mg and 25 mg, used to treat epilepsy and seizures, the company informed stock exchanges on July 17.
Alkem Labs Generic Topiramate Receives Approval in US
Xiamen LP Generic Topiramate Receives Tentative Approval Approval in U.S.
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
Enforcement Report - Week of January 10, 2024
Dr. Reddy`s Generic Topiramate Receives Approval in the U.S.
Ajanta Pharma's Generic Topiramate Receives Approval in US
Par's Generic Topiramate Receives Receives Approval in the U.S.
FDA Confirms Paragraph IV Patent Litigation for Topiramate Extended-release Capsules